Ranibizumab in Diabetic Macular Oedema – A Benefit–risk Analysis of Ranibizumab 0.5 mg PRN Versus Laser Treatment

por Ziemssen, Focke, Cruess, Alan, Dunger-Baldauf, Cornelia, Margaron, Philippe, Snow, Howard, Strain, William David
Publicado 2017